STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

22.22B

Vuru Grade

63.43/100

Current Price

$78.18
+0.34 (+0.44%)

Growth Price

$42.87
Overvalued by 45.16%

Stability Price

$7.56
Overvalued by 90.33%

Company Metrics

  • P/E 31.41
  • P/S 3.92
  • P/B 5.39
  • EPS 2.49
  • Cash ROIC 13.51%
  • Cash Ratio 0.27
  • Dividend 1.24 / 1.60 %
  • Avg. Vol. 3.75M
  • Shares 284.22M
  • Market Cap. 22.22B

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Overbuying Stock on Analysts Radar: St. Jude Medical, Inc. (NYSE:STJ)
The Point Review - 12 hours ago
St. Jude Medical, Inc. (NYSE:STJ) has an ABR 2.62 which is the combined stock view of 21 analysts' poll results.
Analysts: St. Jude Medical, Inc. (NYSE:STJ) Stock Could Go to 89.00 - CWRU Observer
Key Stocks of the Day: St. Jude Medical Inc. (NYSE:STJ) - The News Journal
Why St. Jude Medical, Inc. Acquired a Higher Price Today
Motley Fool - Apr 28, 2016
What: St. Jude Medical (NYSE:STJ) is up about 28% at 11:30 a.m. EDT on news that the medical-device maker agreed to be acquired by Abbott (NYSE:ABT).
Abbott Laboratories to buy St. Jude Medical for $25 billion - USA TODAY
Why St. Jude Medical Inc. Stock Popped 38.1% in April
Motley Fool - May 5, 2016
What: Shares of St. Jude Medical Inc (NYSE:STJ), a company focused on the development, manufacture and distribution of cardiovascular medical devices popped 38.1% in April, according to data from S&P Global Market Intelligence.
St. Jude Medical, Inc. (NYSE:STJ) Given Downgrade Rating at Morgan Stanley - The Point Review
Stock Downgrades: St. Jude Medical Inc. (STJ) - CWRU Observer
St. Jude Medical Inc. (NYSE:STJ) missed earnings on 0 occasions
Zergwatch - May 26, 2016
St. Jude Medical Inc. (NYSE:STJ) is expected to announce second quarter financial results before market open (confirmed) on July 13, 2016.
Analyst Review Alert: St. Jude Medical, Inc. (NYSE:STJ)
CWRU Observer - May 25, 2016
Analysts are weighing in on how St. Jude Medical, Inc. (NYSE:STJ), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.8.
What Wall Street is saying about St. Jude Medical, Inc. (NYSE:STJ) - Zergwatch
St. Jude Medical, Inc. (NYSE:STJ) EPS Estimate At $1.01 - Enterprise Leader
Healthcare Stocks to watch: Baxalta Incorporated (NYSE:BXLT) , St. Jude ...
Is stories - 13 hours ago
In most recently trading session on 5/26/2016, St. Jude Medical, Inc. (NYSE:STJ) climbed +0.52% while traded on 1.81 million shares versus it's an average volume of 3.77 million shares.
St. Jude Medical, Inc. (NYSE:STJ) Tracking Stock Rating and Target Projections
The Post - 20 hours ago
Out of the 18 covering Wall Street analysts providing share ratings for St. Jude Medical, Inc. (NYSE:STJ), 4 have rated the stock as a Strong Buy while 0 analysts have the stock listed as a Buy.
Notable Analyst's Ranking Preview: Boston Scientific Corporation (NYSE:BSX ...
Street Updates - May 25, 2016
In the past trading session, St. Jude Medical, Inc. (NYSE:STJ) highlighted upward shift of +0.93% or +0.71 points to $77.01.
Investor's Watch on Overbuying: St. Jude Medical, Inc. (NYSE:STJ)
The Point Review - May 19, 2016
St. Jude Medical, Inc. (NYSE:STJ) has an ABR 2.62 which is the combined stock view of 21 analysts poll results.
St. Jude Medical, Inc. (NYSE:STJ) Overbought by Traders
The Point Review - May 16, 2016
As of writing, St. Jude Medical, Inc. has a price to earnings ratio of 18.68. Taking a step further, investors can also look to a firm's price to earnings growth or PEG ratio.